Our future studies will focus on the molecular mechanism of MS17-57 inhibition of cancer cells proliferation and migration via binding to PALP/IALP on the cancer cell surface, and on clarifying intracellular signaling pathways affected by the action of this antibody. Here, ALPP is linked to cancer.